Latest news with #STEMI
Deccan Herald
9 hours ago
- Health
- Deccan Herald
Panic-stricken people flock to Jayadeva Hospital as cardiac arrest deaths rise
Kalaburagi: The reports of an increase in heart attack cases in Hassan has created panic among the general public, with more people starting to visit Sri Jayadeva Institute of Cardiovascular Sciences and Research here for heart-related May, the number of new patients visiting the out-patient department (OPD) for health check-ups was up to 4,900, and this has increased to 5,535 in June. However, the people admitted for treatment have not witnessed much increase despite the rise in the number of new OPDs.A total of 9,708 people, including old and new patients, visited the OPD in January. Of these, 686 patients (7.06 percent) were admitted for treatment. Out of a total of 11,056 visits in June, 798 patients (7.21%) were admitted. Hospital doctors said that there is no significant increase in the number of OPDs increased, there has also been a rise in heart-related ECG, 2D echo-cardiogram, treadmill test, biochemistry, and pathology tests. In January, 7,390 ECGs, 4,535 2D echo-cardiogram tests, 199 treadmill tests, 14,699 biochemistry and 5,023 pathology tests were performed. In June, 8,666 ECGs, 4,599 2D echo-cardiogram tests, 274 treadmill tests, 17,090 biochemistry and 5,9024 pathology tests were performed."People are coming to the hospital in large numbers out of anxiety and requesting for heart-related treatment after watching news in the media. Treatment is being provided based on their medical condition. The daily OPD patients have increased to 600 as against 400 patients just two weeks ago. They are coming out of anxiety even if they have heartburn due to gastritis", the hospital cardiologist and in-charge medical superintendent, Dr Viresh Patil, said. 371-bed hospitalThe expansion of the branch from the 135-bed hospital to the 371-bed hospital has added more strength to the government healthcare, as poor and middle-class people from backward Kalyana Karnataka region can avail treatment at affordable rates. The new building was thrown open to the public in December last autonomous institute has also launched the Segment Elevation Myocardial Infarction (STEMI) programme to link all government taluk hospitals in Kalaburagi, Yadgir and Bidar districts with it as part of its initiatives to expand affordable heart-care services to the poor and marginalised sections in rural areas. The doctors in these taluks have been trained about handling heart-related diseases with preliminary medication and procedures such as electrocardiogram (ECG) performed for the heart-attack patients at these taluk hospitals would be immediately transmitted to the SJICR branch office in Kalaburagi or its main campus in Bengaluru where expert cardiologists would examine the reports and guide the doctors about handling the cases in taluk hospitals. After the three-hour golden period of screening and preliminary treatment during the heart attack, the patients would be shifted to Kalaburagi branch hospital for further procedures such as angiogram and angioplasty.
Hindustan Times
a day ago
- Health
- Hindustan Times
Punjab expands STEMI project for heart attack patients
CHANDIGARH Punjab Health minister Dr Balbir Singh Health minister Dr Balbir Singh on Tuesday launched the state-wide expansion of the Punjab STEMI Project on National Doctors' Day, empowering all the district and sub-divisional hospitals across the state to give thrombolysis treatment by administering a clot buster drug Tenecteplase to save patient life in case of heart attack. This ambitious initiative, also known as 'Mission Amrit' (Acute Myocardial Reperfusion in Time), aims to dramatically improve outcomes for patients experiencing ST-Segment Elevated Myocardial Infarction (STEMI), the most severe type of heart attack. The minister accompanied by principal secretary health Kumar Rahul and professor and head of cardiology at DMCH-Ludhiana Dr Bishav Mohan, launched the project here and said that the Tenecteplase injection, which costs around ₹ 30,000, is being administered free of cost under this project. 'This injection helps to dissolve blood clots in the heart,' he added. The project was launched across the state after the success of a pilot project, which was initially implemented in two districts— Ludhiana and Patiala— and extended to nine more districts later. In the pilot stage, approximately 14,000 chest pain patients have been enrolled, and out of 1305 STEMI patients identified, 583 have successfully received thrombolysis at district health facilities. To ensure project's success, the minister said that over 700 staff members, including medical specialists, emergency medical officers (emos), and staff nurses from all 23 districts, have undergone intensive capacity-building training programmes at DMCH-Ludhiana.
News18
2 days ago
- Health
- News18
'Not Just Hassan': Area MP Shreyas Patel To News18 On Spike In Heart Attack Deaths Of Youths
Asked why Hassan is in the spotlight, he said it's because every cardiac-related death is being tracked, documented, and responded to seriously It's not just Hassan, but several districts in Karnataka and across India are seeing a rise in young people dying of heart attacks, said Hassan MP Shreyas Patel in an exclusive interview with News18. Asked why Hassan is in the spotlight, he said it's because every cardiac-related death is being tracked, documented, and responded to seriously. 'We are keeping a close watch on heart attack cases, especially among the 18-40 age group, which is why the numbers look high. It's not only happening here, but we are logging every heart-related issue or death and monitoring it closely," he said. The spike in heart attack-related deaths in Hassan prompted the Siddaramaiah government, the local district administration, and the health department under minister Dinesh Gundu Rao to launch a probe into the matter. Karnataka health commissioner Randeep D also sought a report on the Hassan cardiac deaths, calling them concerning. Chief minister Siddaramaiah said on Monday that the government would identify and resolve the underlying problem, adding that directions have been given to the health department to form a committee. According to MP Patel, Hassan's medical institutions immediately launched a coordinated response. 'Over the past month, we've been tracking every case. On June 17, we had a detailed meeting with the district health officer, the director of HIMS, cardiologists from HIMS and private hospitals. We took stock of the situation and began taking action immediately," said the MP. Training has also been prioritised. 'We've directed all assistant medical officers that any patient suspected of having a heart attack must be treated without delay. Not just doctors—every healthcare worker, including staff nurses and support staff, must know what to do as immediate first aid. We've already begun batch-wise training for all medical staff since June 17," he confirmed. The district has also begun implementing the STEMI system—a real-time video consultation setup operated directly by a team of cardiologists from Jayadeva Hospital. Patel said the system has already been installed in three to four hospitals and that they have requested the health minister to extend it to all CHCs. 'He has agreed in principle, and we hope to get approval soon," the MP said. But beyond infrastructure, he insisted that awareness is key. 'People should cooperate with us. They should regularly undergo checkups—echocardiograms, TMT, and ECG. All of these are free and available at Hassan District Hospital. The public must take advantage of this." When asked why heart attack cases are being reported so extensively from Hassan alone, Patel was quick to clarify: 'No, it's not just Hassan. We are simply maintaining daily accounts—how many deaths have occurred due to heart attacks and how many people have been admitted. Those figures are being put out in the media. That's why it looks like it's concentrated here. But this is an issue for all districts. What's different is how seriously we've taken it." He said the focus now is on preventing deaths among young people. 'The main aim is to protect lives in the 18 to 35 age group. We don't want any more young lives lost to sudden cardiac issues," he said. Patel confirmed that cases in Hassan are being clearly marked as heart attacks, not just broadly listed under 'unnatural deaths", which is the usual classification in many other districts. 'We've been observing the trend carefully for a month. Every heart-related admission or death is recorded. That's the data we've provided to the media," he said. He added that health minister Dinesh Gundu Rao has directed the director of the Jayadeva Institute to submit a detailed report on the Hassan deaths within ten days. 'Once that report is in, we will act based on science and evidence, not panic. But this issue is real, and we're treating it with the urgency it demands," Patel said. First Published:
New Indian Express
2 days ago
- Health
- New Indian Express
21 cardiac deaths in Karnataka's Hassan over 40 days, investigation on
HASSAN: With the district reporting 21 deaths due to heart attacks in the last one month, the Hassan administration held an emergency meeting with senior officials to discuss the issue. Deputy Commissioner KS Lathakumari said a team of experts in Non-Communicable Diseases (NCD)will conduct an investigation and submit a report soon. The report would study the reasons for heart attacks, she added. On Monday, three deaths were reported due to heart attacks. All the recent 21 victims were aged between 30 to 55 years. District Health Officer Dr. Anil Kumar said the deaths may have occurred due to multiple diseases and the exact reason will be known only after the postmortem. According to statistics available with the TNIE, 37,774 people have been treated under ST-Elevation Myocardial Infarction (STEMI) scheme which has been introduced in 68 taluk hospitals three years ago.
Medscape
2 days ago
- Health
- Medscape
Revascularizing Vessels After STEMI Sees Durable Gains
For patients with ST-elevation myocardial infarction, complete revascularization of all vessels with stenosis appears to be a more effective long-term approach than targeting culprit arteries alone, according to a 10-year follow-up analysis of a Danish study. The new findings come from an analysis of patients in the DANAMI-3-PRIMULTI trial, one of several studies between 2017 and 2024 to show the value of complete revascularization, which is now recommended for patients with STEMI and multivessel disease by both US and European guidelines. But those recommendations are based on shorter-term outcomes. The question remained how long the benefits would last, said Thomas Engstrøm, MD, PhD, professor and senior consultant in the Department of Invasive Cardiology at The Heart Center, part of the University of Copenhagen, Copenhagen, Denmark. The latest data, published May 20 in the Journal of the American College of Cardiology , span the longest to date of a study of complete vs culprit-artery revascularization, he said. 'A short term of 1 or 3 years is good to see if a treatment works, but what's more important for patients is whether it is durable,' said Engstrøm, one of the authors of the original study as well as the follow-up analysis. 'Many of our patients are not that old; 10 years is not that long for a patient who has an acute myocardial infarction at 60 years of age.' The follow-up included all 627 patients in the original study, 313 of whom were randomized to culprit-artery revascularization and 314 to complete revascularization. Engstrøm said he and his colleagues manually reviewed hospital records for each patient to ensure they captured any events. Which Benefits Last? Complete revascularization was associated with better outcomes for a combination of death, recurring myocardial infarction, and recurring revascularization (hazard ratio, 0.76 compared with culprit-artery revascularization), according to the researchers. The ability of complete revascularization to prevent further revascularization accounted for the bulk of the difference, with a hazard ratio of 0.62. The results 'add further support for complete revascularization. It shows there's a persistent benefit, especially in regard to the need for repeat vascularization,' said William Fearon, MD, a professor of medicine at Stanford University, chief of interventional cardiology at Stanford University School of Medicine, Stanford, California, and the chief of the cardiology section at the VA Palo Alto Health Care System, Palo Alto, California. He was not involved in the trial. But other outcomes showed less benefit and were not statistically significant. All-cause mortality was almost the same in both groups (hazard ratio, 0.96). Cardiovascular mortality showed a 20% reduction with complete revascularization, but this difference was not statistically significant due to the low number of patients, Engstrøm said. Rates of recurrent myocardial infarction and definite stent thrombosis also were essentially the same in each group, the researchers found (odds ratio, 0.90 for both outcomes). Open Questions Other studies have shown benefit for mortality and myocardial infarction following complete revascularization. The COMPLETE trial in 2019 showed benefits for a combined outcome of cardiovascular death or myocardial infarction after 3 years (hazard ratio, 0.74), driven by a lower rate of recurrent myocardial infarction (hazard ratio, 0.68). At least two factors may explain the discrepancy in findings, Engstrøm said. The COMPLETE trial was much larger, with more than 4000 patients. 'It was more adequately powered to show effects,' Engstrøm said. 'I think the [DANAMI-3-PRIMULTI] study was relatively small relative to some others,' Fearon said. 'So, that limits the ability to look at specific endpoints that have a lower incidence.' 'What we're learning is that, for harder endpoints like [myocardial infarction], the benefit is really in more severe lesions.' DANAMI-3-PRIMULTI did not analyze patient outcomes by severity of lesions, whereas the COMPLETE trial did, he noted. In addition, revascularization was guided by different methods in the two trials. In DANAMI-3-PRIMULTI, complete revascularization was guided by fractional flow reserve (FFR) measurements, whereas the COMPLETE trial involved angiography-guided revascularization. 'The COMPLETE trial used a less stringent way of defining the lesions, by angiography. These lower-grade stenoses were not identified by FFR,' Engstrøm said. DANAMI-3-PRIMULTI did not measure FFR in patients in whom revascularization involved only the culprit artery, Fearon said. Another study reported in 2017, Compare-Acute, measured FFR in both complete and culprit-artery revascularization groups and found a lower FFR was associated with a higher rate of subsequent events, he said. The COMPLETE-2 trial currently underway is looking at whether FFR or angiography is a better way to measure blood flow in vessels, Engstrøm said. 'The COMPLETE trial showed us that angiography-guided complete revascularization is superior to culprit-artery revascularization,' said Fearon, who is on the steering committee for the COMPLETE-2 study. 'The other trials showed us that FFR-guided complete revascularization is superior, but we don't know whether FFR-guided complete revascularization is superior to angiography-guided complete revascularization.' Studies to date of complete vs culprit-vessel revascularization show 'a very uniform arrow that leads to complete revascularization,' Engstrøm said, 'but there are some corners that have not been shed light on.' Engstrøm is on the advisory board for Novo Nordisk and Abbott Medical. He has received speaker's fees from Abbott Medical, Boston Scientific, and Novo Nordisk. Fearon receives institutional research support from Abbott, CathWorks, and Medtronics. He has received consulting fees or honoraria from Shockwave Medical and from Edwards Lifesciences, and he has stock options in Heartflow.
